Valerie P. Jackson, MD, was named president of the Radiological Society of North America (RSNA) Board of Directors, Wednesday, Nov. 28, at its annual meeting in Chicago.

The ongoing merger between CVS Health and Aetna officially closed Nov. 28, the companies announced. The $69 billion deal brings together one of the nation’s largest health insurers and retail pharmacy chains and pharmacy benefit managers.

The Radiological Society of North America (RSNA) elected Jeffrey S. Klein, MD, to its board of directors at its annual meeting in Chicago. Klein will serve as the board liaison for publications and communications.

The completion of the $67 billion merger between health insurer Cigna and Express Scripts has been delayed, according to a public filing. The deal was anticipated to close by December 8, but the companies have decided to delay that deadline by six months.

In another sign that the cost of healthcare is too high, one hospital system based in Grand Rapids, Michigan, denied a heart transplant to a woman and recommended she try to raise $10,000.

The FDA has announced plans to modernize and finalize its 510(k) clearance pathway as part of a continuing effort to advance the review of safety and effectiveness of medical devices, according to a recent statement from FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health (CDRH).

CMS proposed several new policies for 2020 that aim to lower prescription drug prices by revising how Medicare plans can cover medicines and negotiate prices.

CVS Health received the final approval for its $69 billion merger with the nation’s third-largest health insurance provider, Aetna, on Nov. 26. CVS expects the deal to close Nov. 28, according to a new public filing.